Invasive aspergillosis in the ICU: an emerging disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Who cites it

21 citing papers in PubMed.

1. Diagnostic Approach to Pneumonia in Immunocompromised Hosts.Journal of clinical medicine · 2025
   Review
2. Comparative Analysis of Capsular and Secreted Polysaccharides Produced byJournal of fungi (Basel, Switzerland) · 2023
   Article
3. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.Mycoses · 2020
   Observational
4. Epidemiology of fungal infections in China.Frontiers of medicine · 2018
   Review
5. Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections.Scientific reports · 2017
   Article
6. False-positive galactomannan assay in broncho-alveolar lavage after enteral nutrition solution inhalation: a case report.JMM case reports · 2017
   Article
7. The environmental yeast Cryptococcus liquefaciens produces capsular and secreted polysaccharides with similar pathogenic properties to those of C. neoformans.Scientific reports · 2017
   Article
8. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.Drug development and industrial pharmacy · 2017
   Article
9. Improving diagnostic accuracy for invasive pulmonary aspergillosis in the intensive care unit.Annals of translational medicine · 2016
   Article
10. Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.Critical care (London, England) · 2016
    Observational
11. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis.Current medical mycology · 2015
    Article
12. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.Critical care (London, England) · 2015
    Observational
13. Aspergillus infections in transplant and non-transplant surgical patients.Surgical infections · 2014
    Article
14. Galactomannan antigen assay from bronchoalveolar lavage fluid in diagnosis of invasive pulmonary aspergillosis in intensive care units patients.Advanced biomedical research · 2014
    Article
15. Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Article
16. Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients.Journal of preventive medicine and hygiene · 2013
    Article
17. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project).Infection · 2013
    Article
18. Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study.Infection and drug resistance · 2013
    Article
19. [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].Der Anaesthesist · 2010
    Review
20. Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.Intensive care medicine · 2009
    Article

Corrections and comments

• Comment on
  Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as